Forgot Password?
Return to Course Listing

CME: Updates in psoriasis management: Contemporary practice and novel therapies


Activity Description / Statement of Need:

In this online, self-learning activity:

Psoriasis, characterized by chronic inflammation of the skin and hyperproliferation and abnormal differentiation of the stratified epidermis, is one of the most common autoimmune diseases in the US. With a clinical presentation of red, scaly plaques on the skin that range in severity from minor, localized lesions to complete body coverage, it is also associated with inflammation of the joints and enthesial attachments and has potential of articular destruction—a complication known as psoriatic arthritis that affects up to 30% of those with the disease. Aside from its direct effects on the skin, it is also reduces quality of life associated with cardiac and psychiatric comorbidities. Over half of patients with psoriasis are unsatisfied with their disease management, and half of patients with mild disease are untreated while the same is true for a fifth of patients with severe disease.

This activity has been designed to bring HCPs’ knowledge of current and emerging screening and treatment strategies for psoriasis up to date and to improve their competence and performance in treating it. This program has also been designed to review treatment strategies and raise awareness of gaps in care of patients with psoriasis and review strategies to promote adherence.

Target Audience:

HCPs specializing in: Dermatologists and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in dermatology; and any other healthcare professionals with an interest in or who clinically encounter patients with psoriasis.

Commercial Support Disclosure: This program is supported by an educational grant from AMGEN.

This activity is free of charge.

Release Date: October 05, 2021 -- Expiration Date: October 05, 2023

Faculty: April Armstrong, MD MPD


  • Psoriasis Prevalence in Adults in the United States of America
  • Racial and Ethnic Distribution among Psoriasis Patients in the United States of America
  • Psoriasis Classification: Subtypes
  • Common Locations of Psoriatic Lesions
  • Comorbidities of Psoriasis
  • Overall Treatment Approach for Plaque Psoriasis
  • Topical Mediations for Psoriasis
  • Phototherapy for Psoriasis
  • Highlights in Oral Medications for Psoriasis
  • Biologics for Psoriasis, Including Laboratory Monitoring
  • Helping Patients with Adherence
  • Emerging Therapies
  • Psoriatic Arthritis
  • Cardiovascular Comorbidities
  • Psoriasis and Metabolic Syndrome
  • Screening Recommendations
  • Summary

Learning Objectives

By the end of the session the participant will be able to:

  • Recall the comorbidity-, diagnostic-, and treatment-related healthcare burdens associated with psoriasis.
  • Identify the currently available and emerging pharmacotherapeutic treatments for management of psoriasis.
  • Formulate a treatment plan for a patient with psoriasis, including treatment of the primary and associated diseases.


ACCME Activity #201759866


Faculty Disclosure and Resolution of COI

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

Faculty Disclosure: April W. Armstrong, MD, MPH, Associate Dean and Professor of Dermatology, Vice Chair and Director, Clinical Trials Unit, University of Southern California, discloses that she has received financial compensation for research support from BMS, Leo, UCB, Lilly, Dermavant, Dermira, Pfizer and consulting income from AbbVie, ASLAN, BI, BMS, EPI, Incyte, Leo, UCB, Janssen, Lilly, Novartis, Ortho Dermatologics, Sun, Dermavant, Dermira, Sanofi, Regeneron, Parexel, Pfizer.

Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.

Faculty will not discuss off-label uses.

All relevant financial relationships have been mitigated.

ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Commercial Support Disclosure: This program is supported by an educational grant from AMGEN.


  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.

Additional Courses That Are Related To This Activity

Hereditary angioedema (HAE): Optimizing treatment strategies

The role of cultural competence in healthcare: cultural and linguistic competence

Novel antimicrobials and infectious disease practice: Research updates from ID Week 2019

Alpha-1 antitrypsin deficiency (AATD): Optimizing pharmacotherapeutic management strategies